SyntheticMR’s SyMRI 3D, pending FDA clearance, heralds a transformative era in medical imaging. This pioneering technology introduces unparalleled capabilities, enabling precise brain region analysis and comprehensive lesion assessments. SyMRI 3D’s isotropic resolution promises enhanced…
Continue Reading
4D Medical achieves FDA clearance for CT LVAS, a game-changing CT-based ventilation software complementing its XV LVAS. This advanced technology, showcased at RSNA 2023, enriches CT scans with detailed functional insights, empowering radiologists to…
Continue Reading
ScreenPoint Medical’s Transpara AI has analyzed 5 million mammograms and 1 million Tomosynthesis studies, spotlighting at RSNA 2023. Studies reveal its role as a ‘second pair’ of eyes aiding cancer detection, and reducing recall…
Continue Reading
What You Should Know:
BioIntelliSense, a continuous health monitoring and clinical intelligence company, and California-based UC Davis Health, announce the launch of a new in-hospital monitoring initiative for patients hospitalized for Bone Marrow Transplant and…
Continue Reading
“NeuroShield,” by InMed.AI, secures FDA clearance as a pioneering AI-driven tool quantifying brain volumes from MRI data. This groundbreaking platform offers ethnicity-specific reference ranges and aids neurodegenerative disease diagnosis and treatment planning. With impressive…
Continue Reading
Cytovale, a medical diagnostics company focused on developing technology that helps diagnose diseases, announced it scored $84 million in Series C funding led by Norwest Venture Partners with participation from other investors. WHAT THEY DO
Cytovale…
AI’s impact on healthcare unfolds through HEALWELL AI’s acquisition of Pentavere, fortifying data-driven diagnostics. Forward Health introduces CarePods, reshaping accessibility to comprehensive medical services. Lunit’s FDA clearance for breast cancer detection highlights AI’s pivotal…
Continue Reading
The integration of AI in the healthcare industry could yield remarkable savings for the United States, projected at a staggering US$360 billion. This insight emerged in a report by researchers from McKinsey and Harvard….
Continue Reading
What You Should Know:
SciBase Holding AB, a developer of augmented intelligence-based solutions for skin disorders, has entered into a collaboration agreement with the Skin and Cancer Institute to pilot Nevisense in several of their…
Continue Reading
What You Should Know:
Cytovale®, a commercial-stage medical diagnostics company focused on advancing early detection technologies to diagnose fast-moving and immune-mediated diseases, today announced it has raised $84 million in Series C funding led by Norwest…
Continue Reading
